Aptar Digital Health has signed a licensing agreement with AstraZeneca for detecting CKD using the latter’s AI-driven ...

Sanofi has agreed to acquire Vigil Neuroscience in a $470m deal, nearly a year after investing an initial $40m in the company ...

Eli Lilly and Company has received marketing authorisation from the Australian Therapeutic Goods Administration (TGA) for ...

Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...

Paratek Pharmaceuticals has completed the acquisition of Optinose, valued at almost $330m, broadening its commercial product ...

UK biopharmaceutical companies saw a surge in venture financing for innovator drugs in 2024, with double the total deal value ...

Explore Novotech CEO John Moller's insights on the company's global expansion, commitment to diversity, and innovative ...

Orionis Biosciences has announced a multi-year partnership with Roche’s Genentech for small-molecule monovalent glue medicine ...

To overcome pharma logistics challenges with transporting an MS vaccine, an expert logistics provider was needed.

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

After the FDA asked for more clinical data in May 2025, Moderna has decided to resubmit the BLA later this year.

Viz.ai is to enter a multi-year collaboration with Sanofi and Regeneron aimed at deploying and assessing an AI-powered ...